IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma.

Follicular lymphoma (FL) is the most frequent indolent lymphoma and is characterized by the accumulation of germinal center-derived malignant B cells engaged in a bidirectional crosstalk with their supportive microenvironment in invaded lymph nodes (LNs) and bone marrow (BM). T follicular helper (TFH) cells and infiltrating stromal cells have been shown to favor FL B-cell growth, but the mechanisms of their protumoral effect and how the LN/BM microenvironment is converted into a lymphoma-permissive cell niche remain poorly understood. We demonstrated here that FL-infiltrating LN and BM stromal cells overexpressed CXCL12 in situ. Interleukin-4 high (IL-4hi) FL-TFH cells, unlike FL B cells themselves, triggered CXCL12 upregulation in human stromal cell precursors. In agreement, expression of CXCL12 was associated with IL-4 expression and signaling within the FL BM and LN niches. This IL-4/CXCL12 axis was amplified in activated lymphoid stromal cells as shown in our in vitro model of human lymphoid stroma differentiation and in an inducible mouse model of ectopic lymphoid organ formation. Finally, CXCL12 triggered primary FL B-cell activation, migration, and adhesion, a process antagonized by BTK and PI3K inhibitors. These data identified the IL-4/CXCL12 loop as a previously unrecognized pathway involved in lymphoid stroma polarization and as a potential therapeutic target in FL patients.

[1]  Robert Kridel,et al.  Pathogenesis of follicular lymphoma. , 2017, Best practice & research. Clinical haematology.

[2]  W. Chan,et al.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells , 2016, Cell.

[3]  Peter Johnson,et al.  The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia , 2016, Clinical Cancer Research.

[4]  M. Larrayoz,et al.  IL-4 enhances expression and function of surface IgM in CLL cells. , 2016, Blood.

[5]  B. Ludewig,et al.  Lymphotoxin-Dependent B Cell-FRC Crosstalk Promotes De Novo Follicle Formation and Antibody Production following Intestinal Helminth Infection. , 2016, Cell reports.

[6]  K. Tarte,et al.  Hypoxia Differentially Modulates the Genomic Stability of Clinical‐Grade ADSCs and BM‐MSCs in Long‐Term Culture , 2015, Stem cells.

[7]  B. Ludewig,et al.  Phenotypic and Morphological Properties of Germinal Center Dark Zone Cxcl12-Expressing Reticular Cells , 2015, The Journal of Immunology.

[8]  N. Chiorazzi,et al.  BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia , 2015, Leukemia.

[9]  S. Turley,et al.  Immunological hallmarks of stromal cells in the tumour microenvironment , 2015, Nature Reviews Immunology.

[10]  K. Tarte,et al.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma. , 2015, Blood.

[11]  G. Packham,et al.  Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells. , 2015, Blood.

[12]  K. Toellner,et al.  IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs , 2015, Proceedings of the National Academy of Sciences.

[13]  Anne L. Fletcher,et al.  Lymph node fibroblastic reticular cells in health and disease , 2015, Nature Reviews Immunology.

[14]  K. Tarte,et al.  Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas , 2015, Oncotarget.

[15]  R. Gascoyne,et al.  The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association , 2015, Clinical Cancer Research.

[16]  Karin Tarte,et al.  CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells. , 2015, Blood.

[17]  Burkhard Ludewig,et al.  B cell homeostasis and follicle confines are governed by fibroblastic reticular cells , 2014, Nature Immunology.

[18]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[19]  S. Wienert,et al.  Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells , 2014, The Journal of experimental medicine.

[20]  M. Colombo,et al.  Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies , 2014, Oncoimmunology.

[21]  G. Sutter,et al.  IL-17–induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs , 2014, The Journal of experimental medicine.

[22]  Laurens P. Kil,et al.  Targeting Bruton's tyrosine kinase in B cell malignancies , 2014, Nature Reviews Cancer.

[23]  A. Aguzzi,et al.  Follicular dendritic cells: origin, phenotype, and function in health and disease. , 2014, Trends in immunology.

[24]  K. Tarte,et al.  The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity. , 2014, Seminars in cancer biology.

[25]  F. Tacchini-Cottier,et al.  Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in reactive murine lymph nodes , 2013, Proceedings of the National Academy of Sciences.

[26]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[27]  R. Horton,et al.  Germinal Center Centroblasts Transition to a Centrocyte Phenotype According to a Timed Program and Depend on the Dark Zone for Effective Selection , 2013, Immunity.

[28]  R. Davis,et al.  Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment , 2013, The Journal of Immunology.

[29]  Arnon Nagler,et al.  Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 , 2013, Clinical Cancer Research.

[30]  C. Ware,et al.  Lymphotoxin-β receptor signaling through NF-κB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells. , 2012, Immunity.

[31]  G. Proctor,et al.  Inducible Tertiary Lymphoid Structures, Autoimmunity, and Exocrine Dysfunction in a Novel Model of Salivary Gland Inflammation in C57BL/6 Mice , 2012, The Journal of Immunology.

[32]  K. Tarte,et al.  Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis , 2012, Front. Immun..

[33]  K. Tarte,et al.  Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells , 2012, Leukemia.

[34]  C. Bödör,et al.  Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma , 2012, Histopathology.

[35]  M. Andreeff,et al.  Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma , 2012, PloS one.

[36]  B. Sander,et al.  Entourage: the immune microenvironment following follicular lymphoma , 2012, Blood Cancer Journal.

[37]  K. Tarte,et al.  Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. , 2011, Blood.

[38]  A. K. Church,et al.  Bone marrow stromal cells protect lymphoma B‐cells from rituximab‐induced apoptosis and targeting integrin α‐4‐β‐1 (VLA‐4) with natalizumab can overcome this resistance , 2011, British Journal of Haematology.

[39]  M. Keating,et al.  The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. , 2011, Blood.

[40]  B. Dörken,et al.  Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs. , 2011, Blood.

[41]  R. Roozendaal,et al.  Stromal cell-immune cell interactions. , 2011, Annual review of immunology.

[42]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[43]  Michael J May,et al.  Classical NF-κB Activation Negatively Regulates Noncanonical NF-κB-dependent CXCL12 Expression* , 2010, The Journal of Biological Chemistry.

[44]  Melody A. Swartz,et al.  Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21 , 2010, Science.

[45]  Andreas Radbruch,et al.  Organization of immunological memory by bone marrow stroma , 2010, Nature Reviews Immunology.

[46]  S. Stilgenbauer,et al.  Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. , 2009, Blood.

[47]  J. D. Vos,et al.  Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis , 2009, Leukemia.

[48]  S. Ansell,et al.  Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma. , 2009, Cancer research.

[49]  A. Cumano,et al.  Inflammation Recapitulates the Ontogeny of Lymphoid Stromal Cells1 , 2009, The Journal of Immunology.

[50]  E. Jaffe,et al.  IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. , 2008, Blood.

[51]  E. Schwarz,et al.  TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood , 2008, Arthritis research & therapy.

[52]  K. Tarte,et al.  Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. , 2007, Blood.

[53]  Xuelin Huang,et al.  Germinal centre‐like versus undifferentiated stromal immunophenotypes in follicular lymphoma , 2003, The Journal of pathology.

[54]  L. Medeiros,et al.  The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B‐cell tumours , 2002, British journal of haematology.

[55]  T. Kipps,et al.  Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. , 2001, The Journal of clinical investigation.

[56]  S. Sozzani,et al.  Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. , 2000, Journal of the National Cancer Institute.

[57]  K. Rajewsky,et al.  Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin β and Tumor Necrosis Factor by B Cells , 1999, The Journal of experimental medicine.

[58]  D. Calado,et al.  Germinal Centers , 2017, Methods in Molecular Biology.

[59]  D. Link,et al.  Regulation of hematopoietic stem cells by bone marrow stromal cells. , 2014, Trends in immunology.

[60]  P. Cirri,et al.  Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.

[61]  J. Newcombe,et al.  Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. , 2006, Brain : a journal of neurology.